Correlation Between Syndax Pharmaceuticals and Sellas Life
Can any of the company-specific risk be diversified away by investing in both Syndax Pharmaceuticals and Sellas Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Syndax Pharmaceuticals and Sellas Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Syndax Pharmaceuticals and Sellas Life Sciences, you can compare the effects of market volatilities on Syndax Pharmaceuticals and Sellas Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Syndax Pharmaceuticals with a short position of Sellas Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Syndax Pharmaceuticals and Sellas Life.
Diversification Opportunities for Syndax Pharmaceuticals and Sellas Life
0.74 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Syndax and Sellas is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Syndax Pharmaceuticals and Sellas Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sellas Life Sciences and Syndax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Syndax Pharmaceuticals are associated (or correlated) with Sellas Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sellas Life Sciences has no effect on the direction of Syndax Pharmaceuticals i.e., Syndax Pharmaceuticals and Sellas Life go up and down completely randomly.
Pair Corralation between Syndax Pharmaceuticals and Sellas Life
Given the investment horizon of 90 days Syndax Pharmaceuticals is expected to generate 7.05 times less return on investment than Sellas Life. But when comparing it to its historical volatility, Syndax Pharmaceuticals is 1.4 times less risky than Sellas Life. It trades about 0.04 of its potential returns per unit of risk. Sellas Life Sciences is currently generating about 0.22 of returns per unit of risk over similar time horizon. If you would invest 90.00 in Sellas Life Sciences on October 20, 2024 and sell it today you would earn a total of 16.00 from holding Sellas Life Sciences or generate 17.78% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Syndax Pharmaceuticals vs. Sellas Life Sciences
Performance |
| Timeline |
| Syndax Pharmaceuticals |
| Sellas Life Sciences |
Syndax Pharmaceuticals and Sellas Life Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Syndax Pharmaceuticals and Sellas Life
The main advantage of trading using opposite Syndax Pharmaceuticals and Sellas Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Syndax Pharmaceuticals position performs unexpectedly, Sellas Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sellas Life will offset losses from the drop in Sellas Life's long position.| Syndax Pharmaceuticals vs. Cogent Biosciences | Syndax Pharmaceuticals vs. Cullinan Oncology LLC | Syndax Pharmaceuticals vs. Kalvista Pharmaceuticals | Syndax Pharmaceuticals vs. Mersana Therapeutics |
| Sellas Life vs. NLS Pharmaceutics AG | Sellas Life vs. Mereo BioPharma Group | Sellas Life vs. Day One Biopharmaceuticals | Sellas Life vs. Reviva Pharmaceuticals Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |